GENE ONLINE|News &
Opinion
Blog

Judy Ya-Hsuan Lin

Success is the ability to go from one failure to another with no loss of enthusiasm.

WRITTEN BY Judy Ya-Hsuan Lin

J&J’s FDA-Approved Bispecific Antibody Registers Promising Phase 1 Results for a Different Indication
2021-08-20
FDA Rejects Sesen Bio’s Bladder Cancer Drug Application, Asks Additional Data
2021-08-16
Canada Signs Deal with Moderna to Build Vaccine Plant in the Country
2021-08-12
Seagen Licenses ADC Asset From a Chinese Player to Disrupt HER2 Market
2021-08-10
BMS Wins Agenus’ anti-TIGIT Asset to Bolster I-O Pipeline
2021-05-21
Amgen Makes Second Acquisition Move Within a Month, Bolsters Inflammatory Disease Portfolio
2021-04-02
Frequency Looks to Refocus After Sensorineural Hearing Loss Drug Suffers Setback
2021-03-27
Monte Rosa Bags $95 Million Series C Funding to Advance Protein Degraders
2021-03-14
After Five Year Oncology Alliance, Takeda Acquires Maverick to Embark on Solid Tumor Quest
2021-03-10
Jaguar Launches with a Pre-clinical Pipeline of AAV9-Based Gene Therapies
2021-02-28
Clover Biopharmaceuticals Raises $230 Million to Expand Trimer-Tag Technology
2021-02-28
BITT’s TNFR2 Antagonist to Enter Clinical Trials In Collaboration with BeiGene
2021-02-20
Bluebird Bio Temporarily Suspends Sickle Cell Trials Following Cancer Diagnosis in Two Patients
2021-02-18
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
BeiGene’s Immunotherapy Drug Shines in Phase ESCC Trial
2021-01-31
1 2 3 4 … 6
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top